F-1/A: SMX (Security Matters) Public Limited Company Eyes $10.7 Million Boost Through Warrant Exercises

Sentiment:

Prospectus


SMX (Security Matters) Public Limited Company is registering for resale up to 32,755,097 ordinary shares, potentially yielding $10.7 million upon warrant exercises.

Capital raiseThe company entered into a private placement transaction for aggregate gross proceeds of $5.350 million.The offering consisted of the sale of 5,350,000 Common Units (or Pre-Funded Units), each consisting of one Ordinary Share or Pre-Funded Warrant and two Series A Common Warrants, each to purchase one Ordinary Share per warrant at an exercise price of $1.00, subject to adjustment, and one Series B Common Warrants to purchase such number of Ordinary Shares as determined in the Series B Warrant.

Summary

  • SMX (Security Matters) Public Limited Company has filed an amendment to its Form F-1 registration statement.
  • The document pertains to the resale of up to 32,755,097 ordinary shares.
  • These shares are linked to a private placement transaction involving common units, pre-funded warrants, and Series A and B common warrants.
  • The company could receive up to approximately $10.7 million if all warrants are exercised for cash.
  • The selling stockholders will determine the sale prices, which may be at prevailing market rates or negotiated privately.
  • The company will not receive any proceeds from the sale of ordinary shares by the selling stockholders.
  • The company is identified as an emerging growth company and a foreign private issuer, entitling it to certain exemptions from reporting requirements.
  • The document highlights various risk factors associated with investing in the company's securities.

Sentiment

Score: 5

Explanation: The document is primarily factual and descriptive, outlining the terms of a securities offering. While the potential for raising capital is positive, the inclusion of risk factors tempers the overall sentiment.

Positives

  • Potential for the company to receive up to $10.7 million from warrant exercises.
  • The company's status as an emerging growth company and foreign private issuer provides certain regulatory advantages.

Negatives

  • The company will not receive any proceeds from the resale of ordinary shares by the selling stockholders.
  • The document highlights various risk factors associated with investing in the company's securities.

Risks

  • The market for the company's securities may not continue, affecting liquidity and price.
  • The company may need to raise additional funds in the future, which may not be available on acceptable terms.
  • The company's industry is competitive, and failure to compete effectively could reduce margins or revenues.
  • The company's financial statements contain an explanatory paragraph regarding substantial doubt about its ability to continue as a going concern.
  • The company's management has limited experience in operating a public company in the United States.
  • The company may lose its foreign private issuer status, leading to significant additional costs and expenses.

Future Outlook

The company intends to use the net proceeds from the Private Placement for general corporate purposes and for working capital purposes.

Industry Context

The document relates to a company in the anti-counterfeit and track and trace technology sector, which is increasingly relevant due to the growing emphasis on supply chain integrity, brand protection, and sustainability.

Stakeholder Impact

  • Shareholders may experience dilution due to the issuance of new shares.
  • The company's ability to execute its business plan may be affected by the availability of capital.

Next Steps

  • The selling stockholders may sell the Ordinary Shares at prevailing market or privately negotiated prices.
  • The company will file a registration statement for the registration under the Securities Act of the Ordinary Shares issuable upon exercise of the Public Warrants.

Key Dates

DateDescription
2022-07-26Date of the Business Combination Agreement between SMX and Lionheart III Corp.
2023-03-07Closing date of the Business Combination.
2024-09-11Date of the Securities Purchase Agreement for the Private Placement.
2024-10-18Closing price of Ordinary Shares was $2.68.
2024-10-22Date of the prospectus.

Keywords

Ordinary Shares, Warrants, Private Placement, Emerging Growth Company, Foreign Private Issuer, Resale, Securities, SMX

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.